Back to Crinetics Pharmaceuticals, Inc.

Crinetics Pharmaceuticals, Inc.

All insider transactions

20 transactions

DateMoveSecurityInsiderΔ sharesPriceValueHeld afterImpact
Jun 18, 2026Other
Grant / award
Common StockFust Matthew K
Director
+5,925$0.00$028,761low
Jun 18, 2026Other
Grant / award
Common StockBedrosian Camille L
Director
+5,925$0.00$022,225low
Jun 18, 2026Other
Grant / award
Common StockWIERENGA WENDELL
Director
+5,925$0.00$0122,071low
Mar 16, 2026SellCommon StockStruthers Richard Scott
CEO
-8,785$37.77$331.8K404,778medium
Mar 16, 2026SellCommon StockStruthers Richard Scott
CEO
-13,196$37.11$489.7K413,563medium
Mar 16, 2026SellCommon StockKnight Jeff E.
Executive
-3,961$37.77$149.6K112,018medium
Mar 16, 2026SellCommon StockKnight Jeff E.
Executive
-5,950$37.11$220.8K115,979medium
Mar 16, 2026SellCommon StockBetz Stephen F.
Executive
-4,241$37.77$160.2K137,101medium
Mar 16, 2026SellCommon StockBetz Stephen F.
Executive
-6,371$37.11$236.4K141,342medium
Mar 12, 2026SellCommon StockVivaldi Coelho Rogerio
Director
-523$36.77$19.2K16,300low
Mar 12, 2026SellCommon StockVivaldi Coelho Rogerio
Director
-4,477$36.08$161.5K16,823medium
Mar 3, 2026SellCommon StockOkey Stephanie
Director
-3,000$39.67$119.0K13,300medium
Mar 3, 2026SellCommon StockSchilke Tobin
Executive
-6,713$39.67$266.3K78,121medium
Feb 23, 2026Other
Grant / award
Common StockStruthers Richard Scott
CEO
+62,000$0.00$0426,759low
Feb 23, 2026Other
Grant / award
Common StockSchilke Tobin
Executive
+32,000$0.00$084,834low
Feb 23, 2026Other
Grant / award
Common StockKnight Jeff E.
Executive
+34,000$0.00$0121,929low
Feb 23, 2026Other
Grant / award
Common StockBetz Stephen F.
Executive
+30,000$0.00$0147,713low
Feb 23, 2026Other
Grant / award
Common StockKalofonos Isabel
Executive
+34,000$0.00$034,834low
Jan 5, 2026SellCommon StockKalofonos Isabel
Executive
-2,500$55.00$137.5K834medium
Jan 5, 2026Other
Option exercise
Common StockKalofonos Isabel
Executive
+2,500$40.59$101.5K3,334low
← PrevPage 1 of 1Next →